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Single molecule microscopyHyaluronan and its receptor CD44 are known to contribute to the invasive growth of different tumors of the
central nervous system. It is not known, however, if CD44 is sufﬁcient to activate invasive growth into the
brain tissue. This study examines how CD44 regulates the motility and invasive growth of B35
neuroblastoma cells into a hyaluronan-rich environment. A comprehensive experimental approach was
used encompassing biochemical techniques, single molecule microscopy, correlative confocal and scanning
electron microscopy, morphometry of cellular extensions, live-cell imaging and tracking, transplantation
onto organotypic brain slices, two-photon imaging and invasion assays. We found that CD44-GFP fusion
protein was localized in ﬁlopodia and in focal bleb-like protrusions where it provided binding sites for
hyaluronan. Transient expression of CD44-GFP was sufﬁcient to increase the length of ﬁlopodia, to enhance
cell migration and to promote invasive growth into hyaluronan-rich brain tissue. Thus, CD44 controls
molecular devices localized in ﬁlopodia and bleb-like specializations of the cell surface that enhance cell
migration and invasive growth.e phosphatase; BSA, Bovine
44s, Standard form of CD44;
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Invasive growth is a complex biological program that plays a
central role during normal embryogenesis [1,2]. Its re-activation is an
important step during wound healing but also during the formation of
metastases of malignant tumors [1,2]. A precise understanding of the
molecular mechanisms of invasive growth will allow the design of
inhibitors of inappropriate invasive growth e.g. for the treatment of
glioblastomas for which a cure is still not available [3]. On the other
hand, controlled activation of invasive growth would be important for
cell-based therapeutic strategies targeting tissues with limited
capacity of self repair such as the brain. Currently, intense efforts
are made in the ﬁeld of neurodegenerative diseases to use embryonic
stem cell-derived neural precursor cells for cell replacement [4].
However, the capacity of stem cell-derived cells for tissue invasion
and integration often is a limiting factor. Therefore, there is a search
for molecules that activate invasive growth in neural precursor cell
types [5,6].
During invasive growth cellular interactions with the extracellular
matrix (ECM) are very important [1]. Hyaluronan (HA) is a key
component of the ECM of the brain [7]. In the developing brain HA is
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speciﬁc neural precursor cell types [8]. Furthermore, interaction of HA
with its receptor CD44 on astrocytes induces their migration in vitro
[9]. Therefore, CD44 is a potential candidate molecule for enhancing
the invasive growth of neural precursor cells in brain tissue. The
members of the CD44 family are abundantly expressed transmem-
brane glycoproteins [10]. They mediate cell-matrix adhesion by
coupling the ECM to the actin cytoskeleton via adaptors such as
ankyrin and proteins of the ERM (ezrin/radixin/moesin) family [10]
and act as co-receptors in growth factor signaling [11]. Different forms
of CD44 result from alternative RNA splicing [10], glycosylation [10],
phosphorylation [12] and proteolytic processing [13]. In the normal
adult CNS the so-called standard form of CD44 (CD44s) is expressed
[14]. Several studies show that CD44s or CD44 splice variants are
necessary for the invasive growth of different CNS-derived tumor cell
types in vitro and in vivo [15–25]. So far it is not known, however, if
CD44 is sufﬁcient to activate invasive growth of CNS-derived neural
precursor cells.
In this study we examine how overexpression of CD44 affects the
motility and invasive growth of B35 neuroblastoma cells. Our data
demonstrate that a CD44-GFP fusion protein provides HA-binding
sites at the plasma membrane. Transient expression of CD44-GFP is
sufﬁcient to increase the length of ﬁlopodia-like extensions to
enhance cell migration in vitro. Moreover, CD44-overexpressing cells
invade deeper into the HA-rich tissue of organotypic brain slices.2. Material and methods
2.1. Antibodies
The following primary antibodies were used: puriﬁed rat anti-
mouse CD44 monoclonal antibody IM7 (BD Pharmingen Cat. 553131;
Western blot, WB: 1:5000), mouse anti-rat CD44 monoclonal
antibody 5G8 (gift of Prof. Helmut Ponta, WB 1:1000; [26]), and
rabbit anti GFP polyclonal antibody (abcam, Cat. ab290; IHC: 1:1000).
The following secondary antibodies were used: Cy3-labeled goat anti
rabbit IgG (Jackson Immuno Research, Dianova, Cat. 111-165-003, IHC
1:250), rabbit anti mouse Ig, AP-conjugated (Sigma Aldrich A3687;
WB 1:5000), and AP-conjugated goat anti-rat Ig (Dianova 112-055-
003, WB 1:5000). Neurocan-GFP was prepared as described [27].2.2. Chemicals
All chemicals were purchased from Sigma-Aldrich unless other-
wise noticed.
HAwas coupled to TRITC as described previously [28] (Kaminski et
al., in preparation).2.3. Cloning of CD44-mm-GFP expression plasmid
The full length cDNA clone IRAVp968D0716D coding for mouse
CD44 was obtained from the RZPD/imaGenes (Berlin, Germany) and
the entire coding sequence was veriﬁed by sequencing. The coding
sequence was ampliﬁed by PCR with Taq polymerase (Fermentas)
using the primers 5′-CCAAGCTTATGGACAAGTTTTGGTGGC-3′ and 5′-
CCGAATTCCACCCCAATCTTCATGTC-3′ thereby deleting the stop codon
and incorporating a HindIII restriction site 5′ prime to the start codon
and an EcoRI site downstream of the coding sequence. The resulting
1101 bp DNA fragment was gel puriﬁed, cut with the appropriate
restriction endonucleases, puriﬁed again, cloned into a pcDNA3 vector
and ﬁnally subcloned into pEGFP-N2 using the same restriction
enzymes. Sequencing conﬁrmed that no mutations were contained in
the coding sequence and that it was in frame with the eGFP cDNA.2.4. Cell culture
B35 neuroblastoma cells were grown in DMEM/F12 supplemented
with 10% fetal calf serum, 1% L-glutamine, 100 U/ml penicillin and
100 µg/ml streptomycin. All supplements were purchased from
Invitrogen (Karlsruhe, Germany). Cells were grown in a water-
jacketed incubator (Forma Scientiﬁc, USA) at 37 °C and 5% CO2.
2.5. Nucleofection
For Western blotting 12×106 cells were nucleofected with 18 µg
plasmid DNA in buffer V using program T-20 according to the
instructions of the manufacturer (Lonza).
2.6. Immunocytochemistry
Cells were ﬁxed in 4% paraformaldehyde diluted in culture
medium for 10 min at ambient temperature. After blocking in PBS
containing 3% bovine serum albumin (BSA) and permeabilization
with 0.1% Triton X-100 in PBS for 5 min, cells were incubated with
primary antibodies diluted in 3% BSA/PBS/0.05%Tween for 1 h at
room temperature. After intensive washing, cells were incubated with
the secondary antibodies for 1 h. Subsequently, nuclei were counter-
stained with DAPI and the actin cytoskeleton was visualized with
phalloidin-tetramethylrhodamine isothiocyanate (TRITC) as de-
scribed [29]. The stained cultures were mounted with PBS containing
50% (wt/vol) glycerol and analyzed using an LSM 510 META confocal
microscope (Zeiss) as described [8].
2.7. Single molecule microscopy
Single-particle imaging experiments were performed using a
custom-built single-molecule microscope based on a Zeiss Axiovert
200TV equipped with an 63× NA 1.4 oil immersion objective lens
(Carl Zeiss Microimaging GmbH, Jena, Germany) [30].
Laser illumination was switched on only during image acquisition
by means of an acousto-optical tunable ﬁlter (AA Optoelectronics,
Orsay Cedex, France). For single-particle image acquisition we used
the iXon DV 860 BI camera (Andor Technology, Belfast, Northern
Ireland) in combination with a 4× magniﬁer yielding a pixel size in
the object space of 95.24 nm. Generally, 1000 frameswere recorded in
a single movie, with an integration time of 100 ms and a frame rate of
kacq=5 Hz. Identiﬁcation of the HA-TRITC single-molecule signals was
accomplished using Diatrack 3.0 (Semasopht, North Epping, Austra-
lia), a commercial image processing program for the identiﬁcation and
localization of single-particle signals as described [31]. The image was
divided into plasma membrane, cytoplasmic and extracellular
segments, respectively. The plasma membrane segment was further
divided into subsegments with high and low CD44-mm-GFP ﬂuores-
cence. In each segment the frequency of HA-TRITCmolecules per pixel
and framewas determined and averaged over time and (sub)segment
space. The values obtained for the different segments were compared
using Student's paired t-test.
2.8. Preparation of whole cell extracts
Cells were grown to 90% conﬂuency in 10 cm cell culture dishes
(Falcon), harvested with a rubber police man and collected by
centrifugation at 12,000 g for 5 min. The pellet was suspended in
100 µl HEPES buffer (10 mM HEPES, pH 7.4 150 mM NaCl) supple-
mented with protease inhibitors (1 mM phenylmethylsulfonyl ﬂuo-
ride (PMSF), 1 μg/ml leupeptin, 1 μg/ml pepstatin, 2 mM EDTA), 5%
glycerol and 0,1% Triton X-100 and incubated on ice for 15 min. After
four cycles of sonication (10 s) and cooling (30 s) the homogenate
was incubated for 20 min on ice and then the debris was removed by
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supernatant (C) were used for Western blotting.
2.9. Subcellular fractionation using differential centrifugation
All steps were performed at 4 °C or on ice. Per gram of cell pellet
2.5 ml of buffer (25 mM HEPES, pH 7.4, 5 mM EDTA, 300 mM sucrose
supplemented protease inhibitors) was added and the cells were
homogenized using aspiration with a 22G needle until 80% of the cells
were broken according to phase contrast microscopy. Nuclei were
separated by low-speed centrifugation (at 1000 g for 10 min). The
nuclear pellet (N) was washed once with the respective homogeni-
zation buffer and centrifuged again. The membrane fraction (M) was
pelleted by centrifuging the pooled post-nuclear fractions at 20,000 g
for 30 min. After the removal of the microsomes (Micro) at 120,000 g
for 60 min a supernatant containing soluble proteins (S) was
obtained. Membranes were washed once with hypotonic HEPES
buffer (25 mM HEPES, pH 7.4, 5 mM EDTA, 300 mM sucrose
supplemented with protease inhibitors) and collected by centrifuga-
tion at 20,000 g for 30 min and the supernatant was aspired (Hypo).
Equal aliquots of the fractions were analyzed by Western blotting.2.10. SDS-PAGE and Western blotting
Proteins were electrophoresed on 10% SDS polyacrylamide gels
under non-reducing conditions in a Mini Protean Cell (Bio-Rad,
München, Germany) and silver stained according to standard
protocols or blotted onto nitrocellulose (Schleicher&Schuell, Dassel,
Germany) in a transblot cell (Bio-Rad). AP-conjugated secondary
antibodies were visualized with NBT/BCIP according to the instruc-
tions of the manufacturer (Roche, Mannheim, Germany).2.11. Analytical procedures
Protein was determined using the Biorad DC assay using BSA as
standard.
2.12. Imaging of living cells
For time-lapse videomicroscopy, 20,000 B35 neuroblastoma cells
per well were seeded in a 96-well plate (BD Falcon, Heidelberg,
Germany) (100 µl medium/well) at the day prior to transfection. Cells
were transfected transiently according to the instructions of the
manufacturer using 0.33 µl ExGen 500 (Fermentas, St.Leon-Rot,
Germany) and 0.1 µg of the corresponding plasmid in a total volume
of 5 µl and 50 µl serum-free medium per well. About 19 h after
transfection the medium was replaced by 50 µl DMEM/F12 with 10%
fetal calf serum per well. Two days after transfection the culture plate
was mounted on a Zeiss Axiovert 200 epiﬂuorescence microscope
(Zeiss, Jena, Germany) equipped with a digital CCD camera (Axiocam,
Zeiss), a motorized x–y stage (Scan IM 120_100; Märzhäuser GmbH,
Germany), an automatic shutter and an in vivo incubation chamber
(Incubator XL-3, Pelon GmbH, Germany). 20 images were recorded at
low magniﬁcation (A-Plan 10×, Zeiss) at 15 min intervals using 2×2
binning (1 pixel corresponded to 1.29 µm×1.29 µm). The exposure
time was kept constant for all positions and all time points. Images
were processed with Axiovision 4.1 (Zeiss) and further analyzed using
NIH Image J Version 1.37 (http://rsb.info.nih.gov/ij/).
2.13. Correlative light and scanning electron microscopy
B35 neuroblastoma cell transiently expressing CD44-mm-GFP or
GFP, respectively, were processed for correlative light and scanning
electron microscopy as described [32].2.14. Filopodia induction assay
Coverslips (13 mm) were placed in a 24-well plate, coated with
Poly-D-lysine (100 µg/ml in PBS) for 2 h at 37 °C and washed twice
with PBS. B35 neuroblastoma cells were plated on the PDL-coated
coverslips in a density of 50,000 cells per well, grown overnight and
transfected transiently with ExGen 500 according to the instructions
of the manufacturer. After 24 h the cells were ﬁxed with 4%
paraformaldehyde and the actin cytoskeleton was stained with
phalloidin-TRITC (see above). Cells were photographed using an
Axiovert 100 M epiﬂuorescence microscope (Zeiss) equipped with
Neoﬂuar 40× 1.3 Oil optics and an Axiocam digital camera (Zeiss). The
lengths of cellular processes stained with phalloidin-TRITC were
measured with the ImageJ plugin NeuronJ (http://rsb.info.gov/ij/)
[33]. Calculations were done with MS Excel 2002 and Origin 6.1G. For
statistical testing, the χ2-test was used.
2.15. Cell migration assay
Time stacks of the individual imageswere generated in Image J and
individual ﬂuorescent cells were tracked manually using MTrackJ
(http://www.imagescience.org/meijering/software/mtrackj/). In
MTrackJ a snap range of 19×19–33×33 pixels was chosen to select
the centroid. Except for proliferating cells, all ﬂuorescent B35 cells
that remained during the whole time period within the visual ﬁeld
were tracked. From the x- and y-coordinates of the consecutive
positions of the cells the velocities, path lengths and migration
distances were determined. Furthermore, the ratio of migration
distance and path length was calculated as a measure for the
directional persistence (persistence index). The persistence index is
in the range between 0 and 1. This index correlates with the
directionality of the cellular movement. These calculations were
done with MS Excel 2000.
2.16. HA staining
The distribution of HA in hippocampus slices was visualized with
neurocan-GFP as described [8] using cryosections of the hippocampus
from 8–9 day old Sprague Dawley rats.
2.17. Slice invasion assay
Invasion of transiently transfected B35 neuroblastoma cells was
examined in rat hippocampal slice cultures. Transplantation into slice
cultures was performed as described [34]. Brieﬂy, in vitro transplan-
tation of B35 neuroblastoma cells transiently expressing GFP, CD44-
mm-GFP or EGFR-GFP, respectively, was conducted at day in vitro
(div) 7 of the slice culture. Transfection of these cells was carried out
1 day prior to transplantation using ExGen 500. Brieﬂy, cells were
seeded in 6-well plates (BD Falcon) using 1,000,000 cells and 2 ml of
growth medium per well. On the next day, the medium was replaced
by serum-free medium (1 ml per well). Per well 2 µg of plasmid DNA
and 6.6 µl of ExGen reagent in a total volume of 100 µl were used. Per
slice 150,000 transiently transfected cells in a total volume of 0.2 µl
were deposited on the surface of the entorhinal cortex (EC) 19 h after
transfection. Slices were washed thoroughly with medium to remove
non adherent donor cells 2 days after application. 3 days after
transplantation the slices were ﬁxed with 4% PFA overnight at 4 °C
and stained with an anti-GFP antibody. All incubations were carried
out under agitation at room temperature unless otherwise noticed. All
solutions contained 0.1% (w/v) sodium azide. Non speciﬁc binding
sites were blocked with 10% normal goat serum (NGS) dissolved in
PBS/0.1% Triton X-100 (overnight, 4 °C). The slices were incubated
with the primary anti GFP antibody (diluted 1:1000 in PBS/0.1%
Triton X-100/5% NGS) for 8 h. After washing with PBS/0.1% Triton X-
100 overnight at 4 °C the secondary antibody (Cy3-labeled goat anti
Fig. 1. Characterization of CD44-mm-GFP. A. Schematic representation of the CD44-mm-GFP fusion construct. N- and C-termini are localized as indicated. The boxes represent the
HA-binding domain (brown), the stalk region (light brown), the transmembrane (TM) region (brown), the cytosolic domain (light brown) and the GFP module (green). B. Western
blotting analysis of CD44-mm-GFP after transient expression in B35 neuroblastoma cells. Membrane fractions of parental cells (B35/M, C6/M) and of transfected cells (B35 CD44-
GFP/M) and the supernatant of transfected cells (B35 CD44-GFP/S) were separated by SDS-PAGE as indicated at the top of the lanes, blotted and probed using the monoclonal
antibody IM7. The position of molecular weight marker bands is shown at the left (in kDa) and the apparent molecular weights of CD44-mm-GFP derived protein bands in the
supernatant are shown at the right. C. Epiﬂuorescence microscopy of CD44-mm-GFP after transient transfection of B35 neuroblastoma cells. The CD44-mm-GFP fusion protein
localizes to the plasmamembrane and to distinct structures near themembrane. Bar, 20 µm. D. Confocal microscopy of CD44-mm-GFP-expressing B35 neuroblastoma cells after local
application of HA-TRITC (HA-TRITC). Arrows indicate regions of co-localization of CD44-mm-GFP and HA-TRITC. The open arrowhead indicates binding of HA-TRITC to the surface of
a cell which did not express CD44-mm-GFP. Bar, 10 µm.
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added for 8 h. After a ﬁnal washing step the slices were mounted with
Vectashield (Vector Laboratories) and z stacks at 5 µm intervals were
obtained using a LSM 510 META microscope (Zeiss, Jena, Germany)
equipped with a C-Apochromat 40×/1.2 W corr objective. The laser
excitation intensity and the detector gain were adjusted to minimize
the fraction of overexposed pixels. The ﬁrst image of each stack was
taken at the surface of the slice. For each slice an array of contiguous
stacks centred at the transplantation site in the entorhinal cortex area
was acquired. Thus, these stacks covered an area of approximately
0.51 mm2.
2.18. Two photon microscopy
Slices were analyzed using a confocal laser scanning microscope
(Zeiss 510 META NLO; Plan-Apo 63× oil, NA 1.4). Fluorescence of CY2
was excited at 930 nm (Chameleon; Coherent, Palo Alto, CA) and
epiﬂuorescence was detected in descanned mode with the following
optical ﬁlters: HFT KP 650, SP 680 nm IR (Cy2). For three-dimensional
(3D) reconstruction, image stacks were acquired using a 2P
microscope system with the following pixel spacing (x, y, z): 1.)
GFP: 14×14×240 nm, 2.) CD44: 50×50×150 nm, 3.) EGFR: 70×70×Fig. 2. Simultaneous imaging of single HA molecules and CD44-mm-GFP. A. Distribution of
using alternate two-channel single molecule microscopy (see Material and methods sectio
distribution of CD44-mm-GFP. n=500 frames were obtained at a rate of 5 Hz. Bar, 2 µm. B.
TRITC molecules (ﬂuorescence was excited at 532 nm, integration time 100 ms). C. Overlay o
GFP ﬂuorescence is shown in white. Red pixels represent the positions of HA-TRITCmolecule
excited at 532 nm (500 frames obtained at a rate of 5 Hz). D. Segmentation of the visual ﬁeld
below) regions. The CD44-mm-GFP-rich subsegment of the plasma membrane region is show
different regions. The ratio of all HA-TRITCmolecules encountered to the number of pixels of
frame ratio. Error bars represent the standard deviation. The mean particle/pixel/frame ratio
ratio of the plasma membrane segment and 7-fold higher compared to of the subsegment240 nm. Image stacks were deconvolved with a theoretical point-
spread function before the construction of 3D iso-surface projection
(AutoQuant, Troy, NY, USA).
2.19. Quantitative analysis of invasive growth
For calculating and verifying the depth of invasive growth of
transfected cells into the slice tissue two different analyses were
carried out.
2.19.1. Maximal invasion depth
Each plane of a stack was examined for the presence of green
ﬂuorescent cells to determine the maximum invasion depth. For each
construct a total number of four separate slices obtained in two
independent transplantation experiments were analyzed. From the
resulting image stacks the mean and the SD of the maximal invasion
depth were calculated and compared using Student's t-test.
2.19.2. Signal intensity distribution along the z-axis
The intensity distribution of the ﬂuorescence signal along the z-
axis was calculated to determine an observer-independentmeasure of
invasive growth. For this analysis it was necessary to improve theCD44-mm-GFP in B35 neuroblastoma cells. Transiently transfected cells were imaged
n). Time-averaged projection of the ﬂuorescence excited at 488 nm representing the
Single molecule imaging of HA-TRITC. The panel shows a representative image of HA-
f all positions of HA-TRITC molecules and the distribution of CD44-mm-GFP. CD44-mm-
s obtained by analysis of the entire sequence of images recorded when ﬂuorescence was
into extracellular (black), cytoplasma (grey) and plasma membrane (red and white, see
n in white (CD44). E. Comparison of the encounter frequencies of HA molecules in the
a regionwas calculated for all frames (n=500). Bars represent themean particle/pixel/
in the high CD44-mm-GFP subsegment was 3.3-fold higher in comparison to the mean
with low CD44-mm-GFP (highly signiﬁcant, pb0.001, paired t-test).
Fig. 4. CD44-mm-GFP localizes to ﬁlopodia-like processes and to focal membrane-associated structures in living cells. B35 neuroblastoma cells were plated on PDL-coated glass
coverslips, transfected transiently with CD44-mm-GFP and living cells were imaged using a LSM510META confocal microscope. The successive images of the stack are separated by a
z-distance of 0.25 µm. The main panels show x–y sections at the substrate level (A), through the cell body (B,C) and in an apical plane (D). The subpanels at the top and at the right
show x–z and y–z sections along the white lines shown in the main panels. White lines in the subpanels indicate the focus plane of the respective x–y image. The z-distance between
the planes shown is 0.75 µm. Filled arrows indicate ﬁlopodia-like processes, open arrows indicate focal membrane-associated structures near the proximal end of ﬁlopodia-like
processes, arrowheads indicate putative vesicular structures in the cytoplasm. Bar, 10 µm.
Fig. 3. CD44-mm-GFP co-localizes with F-actin in ﬁlopodia-like processes and in focal structures. B35 neuroblastoma cells were grown on PDL-coated glass coverslips, transfected
transiently with CD44-mm-GFP, ﬁxed, stained with phalloidin-TRITC and photographed using a LSM510 META confocal microscope. A. Phalloidin-TRITC staining. B. CD44-mm-GFP.
C. Overlay (phalloidin-TRITC is shown in red, CD44-mm-GFP in green). Filled arrows indicate ﬁlopodia-like processes, open arrows indicate focal membrane-associated structures
near the proximal end of ﬁlopodia-like processes, arrowheads indicate putative vesicular structures in the cytoplasm. Bar, 10 µm.
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Stacks of confocal images were obtained (see above), images were
exported as JPEG ﬁles in 8 bit greyscale format and the pixel
intensities were analyzed in ImageJ. The mean grey value of an
image corresponded to the ﬂuorescence signal present and thus to the
amount of GFP-positive material. This value was determined usingMS
Excel 2000 for each image. Five contiguous z-stacks which formed a
cross-shaped array centred at the transplantation site were obtained
from a randomly chosen slice and analyzed per condition. Mean and
SD were calculated after background subtraction and normalization
and plotted along the z-axis.
3. Results
3.1. Characterization of a CD44-mm-GFP fusion construct
CD44 was expressed as a fusion construct encompassing the
extracellular, transmembrane and cytoplasmic domains of CD44
(without any domains encoded by alternatively spliced exons) and
a C-terminal GFP tag (Fig. 1A). Western blotting with the monoclonalFig. 5. Correlative light and scanning electron microscopy of B35 neuroblastoma cells exp
palladium-sputtered glass coverslips, transfected transiently with GFP (A,B) or CD44-m
microscope, processed for SEM and scanned using a Philips XL 30 SFEG instrument. Sca
corresponding areas are shown in B,D,F. The black box in panel C represents the area shown a
in panel F. Arrowheads indicate focal bleb-like structures enriched in CD44-mm-GFP. Bars,antibody IM7 directed against the mouse CD44 protein revealed a
single major protein band with the predicted size of approximately
112 kDa corresponding to the sum of the mass of the standard form of
CD44 (85 kDa) and of the mass of GFP (27 kDa) (Fig. 1B). In addition,
minor protein bands of approximately 85 kDa and 35 kDa and a faint
protein band of ca. 30 kDa were noticed. In samples from untrans-
fected B35 neuroblastoma cells only the latter two bands were
detected whereas these bands were not seen when the primary
antibody was omitted (data not shown). In the supernatant of B35
neuroblastoma cells weak protein bands of ca. 110 kDa and 85 kDa
were observed (Fig. 1B). The full length standard form of CD44 was
not detected in untransfected cells. Fluorescence microscopy revealed
a strong signal of CD44-mm-GFP fusion protein at the plasma
membrane and in distinct focal structures that were frequently
associated with cell processes (Fig. 1C).
3.2. Interaction of CD44-mm-GFP and HA-TRITC in living cells
When HA-TRITC was applied to the exterior of B35 cells expressing
CD44-mm-GFP and both ﬂuorophores were monitored using confocalressing GFP or CD44-mm-GFP. B35 neuroblastoma cells were grown on PDL coated
m-GFP (C,D,E,F), respectively, ﬁxed, photographed using a LSM510 META confocal
nning electron micrographs are shown in panels A,C,E. Confocal images of exactly
t higher magniﬁcation in panel E and the grey box in panel D represents the area shown
20 µm (A, B, C, D) and 2 µm (E,F).
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strong CD44-mm-GFP signal was seen (Fig. 1D). Colocalization of HA-
TRITC and CD44-mm-GFP was pronounced in focal structures at the
plasma membrane. Interestingly, cells not expressing CD44-mm-GFP
also bound HA-TRITC to a certain extent, indicating that B35
neuroblastoma cells possess endogenous HA binding sites (Fig. 1D).
To examine quantitatively if HA-TRITC molecules bound preferentially
to regions of the plasma membrane where the CD44-mm-GFP fusion
protein was enriched ultrasensitive single molecule microscopy was
used (Fig. 2). The CD44-mm-GFP positive foci appeared to protrude
from the cell surface and to have circular or oval structures. Imaging of
individualHA-TRITCmolecules suggested thatHA-TRITC bound to these
foci (Fig. 2C). These did not change their shape considerably during the
observation for severalminutes. An overlay of the positions of HA-TRITC
molecules determined in 500 consecutive images obtained at a rate of
5 Hz (Fig. 2C, red dots) and the time-averaged image of CD44-mm-GFP
(Fig. 2C) showed that HA-TRITC molecules were clearly enriched in
regions displaying strong CD44-mm-GFP ﬂuorescence. In contrast, HAFig. 6. Overexpression of CD44-mm-GFP induces ﬁlopodia-like processes. B35 neuroblastom
coding for GFP (A) or CD44-mm-GFP (B). Cells were ﬁxed after 19 h, stained with phalloid
Histograms show the distribution of ﬁlopodia lengths for each condition. Number of cells (nu
panels show representative cells for both conditions after staining with phalloidin-TRITC wmoleculeswereuniformlydistributed in the extracellular space (Fig. 2C)
and the cytoplasm was virtually free of HA-TRITC (Fig. 2C). The
frequency of an encounter with a HA-TRITC molecule at the plasma
membrane was 3.3 fold higher than in the extracellular space (Fig. 2D).
Interestingly, the encounter frequency in the subsegment of the plasma
membrane with high abundance of CD44-mm-GFP was 7 fold higher
than the encounter frequency in the rest of the plasma membrane
(Fig. 2D). This enrichment was highly signiﬁcant (pb0.001, t-test). In
contrast, dextran-TRITC was not enriched at the plasma membrane of
B35 neuroblastoma cells transiently expressing CD44-mm-GFP (Sup-
plemental material S1). Thus, our data show that CD44-mm-GFP
promotes speciﬁc binding of HA.
3.3. CD44-mm-GFP is localized in ﬁlopodia-like processes and focal
structures
The spatial relationship of CD44-mm-GFP protein to the actin
cytoskeleton was investigated using confocal microscopy. CD44-mm-a cells were plated on PDL-coated coverslips and transfected transiently with plasmids
in-TRITC and the lengths of F-actin positive extensions were measured using NeuronJ.
mber of ﬁlopodia) for each condition: A, 15 (247); B: 22(384). Images at the right of the
ith traces of ﬁlopodia-like processes in pink. Bars, 10 µm.
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extensions (Fig. 3). In some of these processes CD44-mm-GFP was
enriched at punctuate structures (Fig. 3, arrowheads). These cellular
processes contained F-actin (Fig. 3), but the CD44-mm-GFP signal did
not colocalize with the F-actin-positive structures within the
processes. In cells not expressing CD44-mm-GFP these thin processes
appeared less prominent (Fig. 3). On the other hand, CD44-mm-GFP
was found in focal structures containing F-actin (Fig. 3, open
arrowhead). Based on these images of ﬁxed cells it was not possible
to decide if CD44-mm-GFP positive processes were ﬁlopodia orFig. 7. Overexpression of CD44-mm-GFP promotes cell migration. B35 neuroblastoma cells w
plates. Cell migration was imaged using epiﬂuorescence microscopy and cells were tracked m
GFP). For statistical analysis data from three independent experiments were pooled. Distr
(n=115; C) and CD44-mm-GFP (n=56; D). The increase of the number of cell migratin
Frequencies of migration persistence indices are shown in E (GFP) and F (CD44-GFP). The inc
was signiﬁcant (pb0.01, χ2 test).retraction ﬁbers. Confocal imaging of living CD44-mm-GFP-expres-
sing cells revealed that many of these processes were attached to the
substratum and seemed to be rather tensely stretched (Fig. 4; arrow).
These processes may correspond to retraction ﬁbers. On the other
hand, CD44-mm-GFP was found in processes without obvious contact
to the substratum. These may correspond to ﬁlopodia. Therefore, we
addressed thin CD44-mm-GFP-positive extensions as ﬁlopodia-like
processes. At the base of these processes often focal structures
containing CD44-mm-GFP were present. Furthermore, arrays of these
focal structures along the membrane edge were observed (Fig. 4).ere transfected transiently with plasmids coding for GFP or CD44-mm-GFP in 96-well
anually. Representative cell tracks are shown in panel A (GFP) and panel B (CD44-mm-
ibution of the relative frequencies of migration velocities (µm/h) are shown for GFP
g with N45 µm/h after transfection with CD44-GFP was signiﬁcant (pb0.05, χ2 test).
rease of cells migrating with an persistence indexN0.5 after transfection with CD44-GFP
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as evidenced by z stacks of optical sections (Fig. 4A, B and C). On the
other hand, focal structures with high CD44-mm-GFP content were
observed at the basal membrane (Fig. 4A). In migrating cells,
prominent focal structures were seen at the distal tips of cellular
processes. These frequently appeared to retract. Individual foci could
be followed for more than 1 h in retracting processes (see Supple-
mental material S2). To conﬁrm that CD44-mm-GFP was present on
rounded protrusions correlative light and scanning electron micros-
copy (SEM) was used (Fig. 5C–F). The overall shapes of the B35
neuroblastoma cells were in general well preserved in SEM images
(Fig. 5). Some minor structural differences were possibly caused by
slight changes such as shrinkage of the samples during the processing
steps for SEM. A careful comparison of the distribution of CD44-mm-
GFP with the 3D structure of cellular processes revealed that the
fusion protein was localized in thin extended processes (Fig. 5C–F).
Furthermore, focal ﬂuorescent structures clearly corresponded to
deﬁned small rounded protrusions with bleb-like appearance accord-
ing to SEM (Fig. 5E and F). There was no indication of general blebbing
of the plasma membrane (Fig. 5C and D). These small bleb-like
structures were less frequent in GFP-expressing control cells (Fig. 5A
and B). Moreover, GFP-expressing cells seemed to form fewer and
shorter of the thin extended processes than the CD44-mm-GFP-
expressing cells (Fig. 5A and B).
3.4. CD44-mm-GFP promotes the formation of ﬁlopodia-like processes
The different morphologies of cells expressing CD44-mm-GFP
and control cells expressing GFP or parental B35 neuroblastoma cells
(compare the CD44-mm-GFP-negative cells in Fig. 3) suggested that
CD44 induced ﬁlopodia-like processes. Quantitative analysis after
plating cells on a PDL-coated glass substratum conﬁrmed a robust
and large increase of the length of ﬁlopodia-like processes after
transient transfection of the CD44-mm-GFP construct in comparison
to GFP-expressing cells (Fig. 6). The mean length of ﬁlopodia-like
processes increased from 4.32 µm (±4.25; SD; n=247 processes, 15
cells) measured for GFP-expressing cells to 8.77 µm (±6.49; SD;
n=384 processes, 22 cells) measured for CD44-mm-GFP-expressing
cells. Thus, expression of CD44-mm-GFP led to an increase of theFig. 8. Distribution of HA in the rat hippocampus at postnatal day 9. Frontal sections ob
ﬂuorescence), cell bodies were counterstained with propidium iodide (red ﬂuorescence) and
of green and red ﬂuorescence. A, overview image of the entorhinal cortex area. The box indica
like structure containing HA. The asterisks indicate a ﬁber-like structure present in correspmean length of ﬁlopodia-like processes of 103% in comparison to
GFP-expressing cells. This difference was highly signiﬁcant when the
numbers of ﬁlopodia-like processes exceeding the mean length after
transient expression of GFP were compared (pb0.01, χ2 test). The
mean number of ﬁlopodia-like processes was 16.5 (±8.4; SD) per
GFP-expressing cell and 17.5 (±13.7; SD) per CD44-mm-GFP-
expressing cell (not signiﬁcant, t-test). In a control experiment the
inﬂuence of transiently expressed GFP on the length of ﬁlopodia-like
processes was examined in comparison to transfection with a
plasmid from which the GFP cDNA was deleted. When 158 processes
of 7 cells expressing GFP were compared with 271 processes of
8 cells expressing the control plasmid, the mean length of ﬁlopodia-
like processes in the latter was slightly larger (+16%). This small
difference was highly signiﬁcant when the number of ﬁlopodia-like
processes exceeding the mean length of GFP-expressing was
compared (pb0.01, χ2 test). The mean number of ﬁlopodia-like
processes per cell did not differ signiﬁcantly between the two
conditions (t-test). These results excluded a strong suppressive
effect of soluble cytosolic GFP on the length of ﬁlopodia-like
processes.
3.5. CD44-mm-GFP enhances the migration of B35 neuroblastoma cells
in vitro
To investigate how the presence of CD44 in motile cellular
protrusions affects cell migration transiently transfected cells were
followed by time lapse videomicroscopy. We found an increased
migration velocity of CD44-mm-GFP-expressing cells compared to
GFP-expressing controls (Fig. 7A, B, C and D). Moreover, migration of
CD44-mm-GFP-expressing cells was clearly more directional as
evidenced by their higher persistence indices (Fig. 7E and F). Data
from three independent experiments were pooled to compare the
distributions of the relative frequencies of migration velocities and
persistence indices for GFP- (n=115; Fig. 7C) and CD44-mm-GFP-
expressing cells (n=56; Fig. 7D). The increased number of cells
migrating with N45 µm/h after transfection with CD44-mm-GFP was
signiﬁcant (*, pb0.05, χ2 test). Furthermore, the increased number of
cells with a persistence indexN0.5 after transfection with CD44-GFP
was highly signiﬁcant (++, pb0.01, χ2 test, Fig. 7E and F).tained from PFA-ﬁxed rat hippocampus were incubated with neurocan-GFP (green
sections were examined with confocal microscopy. The images are shown as an overlay
tes the position of the high power image stack shown in A1. The arrow indicates a ﬁber-
onding x–y, x–z and y–z sections. Bars, 20 µm (A), 2 µm (A1).
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The effect of CD44-mm-GFP on invasive growth into the brain
tissue was examined using transplantation of transiently transfected
B35 neuroblastoma cells into the entorhinal cortex area of rat
hippocampal slices. Staining of these slices with a speciﬁc histochem-
ical probe for HA (neurocan-GFP) [8,27] demonstrated the presence of
HA in the hippocampus (Fig. 8). HA was organized into distinct
deposits with ﬁber-like or punctuate structures (Fig. 8A1). Therefore,
the hippocampal slices appeared to provide a HA-rich environment
which should be able to interact with the HA receptor CD44.
3.7. CD44-mm-GFP is localized in cellular extensions in the brain tissue
Three days after transplantation of CD44-mm-GFP-expressing B35
neuroblastoma cells to the entorhinal area of the hippocampus slicesFig. 9. Two-photon microscopy of B35 neuroblastoma cells expressing GFP, CD44-mm-
GFP or EGFR-GFP in the brain tissue. Transiently transfected B35 neuroblastoma cells
were transplanted onto rat P9 hippocampal slices, ﬁxed after 3 days and examined by
two-photon microscopy. A, GFP. B, CD44-mm-GFP. C, EGFR-GFP. Bars, 30 µm.ﬂuorescent cells were visualized within the slice tissue by confocal and
two-photon microscopy (Figs. 9 and 10). The three dimensional
reconstruction of the cells expressing only the GFP construct (GFP,
control) demonstrated very superﬁcial growthwith only little arborisa-
tion of the cellular processes (Fig. 9A). In contrast, cells expressing
CD44-mm-GFP had long ﬁlopodia-like structures extending deeper into
the brain tissue (Fig. 9B). As a positive control B35 cells expressing the
EGF receptor (EGFR) were used [6]. These cells exhibited a compact
growth pattern with large growth cone-like lamellipodia forming few
short ﬁlopodia (Fig. 9C). EGFR-overexpressing cells also showed
pronounced penetration of the brain tissue. High power micrographs
of cells that had invaded the slices revealed enrichment of CD44-mm-
GFP in ﬁlopodia-like extensions in situ (Fig. 10). Moreover, CD44-mm-
GFP appeared also to be present in bleb-like cellular structures in brain
tissue (Figs. 9B and 10).
3.8. CD44-mm-GFP promotes the invasive growth in brain tissue
Three days after transplantation of B35 neuroblastoma cells onto
brain tissue confocal microscopy demonstrated that CD44-mm-GFP-
expressing cells had invaded more deeply into the brain slices than
GFP-expressing controls (Fig. 11A, B; and E, F). Again, EGFR-GFP was
used as a positive control (Fig. 11C and D) [6]. The maximal invasion
depth of CD44-mm-GFP-expressing cells was about two fold larger
compared to GFP-expressing cells (29.44±5.98 µm, n=9 vs 14.06±
5.07 µm, n=9; pb0.01; t-test). Similar values were obtained in four
separate slices for each condition. Cells transiently overexpressing
EGFR-GFP showed a maximal invasion depth of 44.09±10.62 µm,
whichwas also signiﬁcantly increased compared to GFP cells (pb0.01;
t-test; n=9, Fig. 11G). These means of the maximal invasion depths
corresponded closely to the depths of the half maximal pixel
ﬂuorescence intensity signal (Fig. 11B, D and F). Moreover, similar
ﬁndings were obtained when slices were analyzed 5 days after
transplantation (data not shown). Thus, CD44 overexpression was
sufﬁcient to enhance the invasive growth of B35 neuroblastoma cells
into the brain tissue.
4. Discussion
It was proposed that overexpression of CD44 may cooperate with
other changes to promote tumorigenic phenotypes such as altered cell
proliferation or increased invasiveness, while it may not be sufﬁcient to
promote such cellular behaviours [35]. In the present study we
demonstrate that expression of CD44-mm-GFP (i) provides bindingFig. 10. CD44-mm-GFP is enriched in ﬁlopodia-like processes in situ. 3D reconstruction
of CD44-mm-GFP-expressing cells in the brain tissue. Transiently transfected B35
neuroblastoma cells were transplanted onto rat P9 hippocampal slices, ﬁxed after
3 days and examined by confocal microscopy. Arrows indicate the positions of
ﬁlopodia-like processes. Blue arrows indicate ﬁlopodia-like processes of a second cell.
Bar, 15 µm.
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processes, (iii) promotes cell migration and (iv) is sufﬁcient to promote
invasive growth into a HA-rich environment provided by brain tissue.
4.1. Experimental approach to CD44 function
In all our experiments transient transfections were used to avoid
possible side effects of cloning due to somatic mutations. CD44s of the
mouse was expressed as a C-terminally tagged GFP fusion protein that
displayed an apparent molecular weight of 112 kDa as expected
(Fig. 1B) and localized to the plasma membrane (Fig. 1C). Further-
more, confocal microscopy (Fig. 1D) and ultrasensitive single
molecule microscopy (Fig. 2) after incubation with TRITC-HA
indicated that the GFP-tag does not abolish the binding of the fusion
protein to HA. This is in agreement with the predicted membrane
topology of the fusion protein and with a study on human CD44s
reporting that fusion to a C-terminal GFP tag does not abolish CD44
function [36]. Thus, the CD44-mm-GFP fusion protein provides HA
binding sites that are detectable at the single molecule level at the
plasma membrane. This is the ﬁrst time that the interaction of CD44
with its ligand HA was probed with single molecule ﬂuorescence
microscopy. This approach allowed a straightforward and simple
statistical proof of the enrichment of HA molecules at sites where
CD44-mm-GFP was localized (Fig. 2E). In comparison with conven-
tional co-localization analysis, single molecule microscopy offers a
superior localization accuracy of ﬂuorescence signals and minimiza-
tion of chromatic errors because no changes of optical ﬁlters are
necessary during the measurement.
4.2. CD44 and cellular protrusions
According to our results CD44 is localized in thin ﬁlopodia-like
protrusions (Figs. 3–5). Taking into account the large increase of the
mean length of ﬁlopodia-like processes after expression of CD44-mm-
GFP (+103%; Fig. 6) and the very limited suppressive effect of soluble
cytosolic GFP on the length of such processes we conclude that CD44
promotes the growth of these motile processes. This effect is in
agreement with earlier studies reporting CD44 to be enriched in actin-
based ﬁne cellular protrusions [38,39] and at ﬁlopodia-like structures of
CD34+ bone marrow stem/progenitor cells after stimulation with
SDF1-alpha [40]. Furthermore, Holloway et al. [41] report that the KG1a
cell line extends long, thin CD44-positive podia which can dynamically
extend and retract. Filopodia seem to reﬂect enhancement of cell
migration because some of their key components promote cell motility
[42]. Forced expression of T567D-ezrin, a phosphorylation-mimic form,
enhances ﬁlopodia formation in hippocampal neurons [43] and
promotes the migration of T cells [44]. A similar correlation holds for
CD44 in B35 neuroblastoma cells (Fig. 7). CD44-mm-GFP is also present
in bleb-shapedprotrusionsof theplasmamembrane (Fig. 5E andF)with
high content of F-actin (Fig. 3). In single molecule studies, these focal
structures clearly have a circular distribution of CD44-mm-GFP and HA
binding sites (Fig. 2A,B and C). Membrane blebs as quasi-spherical
membrane segments unsupported by cytoskeleton play a role in cell
migration and chemotaxis [45]. However, while membrane blebs are
rather dynamic structures with a life time in the order of minutes [46],
the roundprotrusions enriched in CD44-mm-GFP inB35neuroblastoma
cells aremore stable. As structureswith a F-actin cytoskeleton theymay
correspond to thebleb-like structures that are described asprecursors of
rufﬂes in spreading CHO cells [47].Fig. 11. CD44-mm-GFP promotes the invasive growth of B35 neuroblastoma cells into the b
onto rat P9 hippocampal slices, ﬁxed after 3 days and Z-stacks were obtained by confocal m
(open bars). Invasion depth was quantiﬁed in ﬁve stacks by the analysis of pixel ﬂuorescence
stacks (error bars, SEM) for B, GFP; D, EGFR-GFP; F, CD44-mm-GFP. Histograms were truncat
represent the mean for at least n=9 separate stacks per condition (error bars, SEM). Hatch
CD44-mm-GFP (29.44±5.98 µm). Statistical analysis using Student's t-test (in each case ve4.3. CD44 and cell migration
The observation that overexpression of CD44 in B35neuroblastoma
cells is sufﬁcient to increase cell migration (Fig. 7) seems to be in
conﬂict with reports indicating that loss of CD44 expression is a strong
predictor of poor prognosis in neural crest-derived neuroblastomas
where CD44-positive tumor cells seem to be less invasive and CD44-
negative tumor cells appear to bemore invasive [48–50]. However, it is
important to notice that the rat brain-derived B35 neuroblastoma cells
used in the present study are clearly distinct from human neural crest-
derived neuroblastoma cells. Therefore, our observations of migration
and invasion enhancing properties of CD44 in B35 neuroblastoma cells
are not in conﬂict with the ﬁndings in neural-crest cell derived
neuroblastomas. Moreover, it was shown that a melanoma cell line
stably transfected with CD44 displayed enhanced motility on HA-
coated surfaces [51]. Furthermore, in vitro experiments with glioma
cells and astrocytes using blocking antibodies have shown that
endogenous CD44 mediates cell migration [9,17]. It has been shown
that ectodomain cleavage of CD44 which is triggered by multiple
stimulations may contribute to cell migration [13]. The ectodomain
shedding subsequently induces the intramembranous cleavage, which
is mediated by γ-secretase. The resulting cytosolic fragment is
translocated to the nucleus and may activate transcription [13].
4.4. CD44-positive protrusions in brain tissue
Abundance of ﬁlopodia is considered to be a characteristic feature
of invasive cancer cells [52]. However, in spite of the fact that ﬁlopodia
share components with invadopodia [53] these structures are clearly
distinct. Invadopodia are characterized by profound invaginations of
the plasma membrane from which many protrusions originate and
sometimes penetrate into the ECM. The speciﬁc function performed
by invadopodia is the local degradation of the ECM [54]. It was
proposed that invadopodia from a cell migrating through a ﬁbrillar
matrix network may resemble ﬁlopodia or lamellipodia-like protru-
sions [55]. Thus, the CD44-mm-GFP positive processes on B35
neuroblastoma cells in hippocampal slices (Figs. 9C and 10) may
correspond to invadopodial structures. In agreement with this
assumption functional interactions of CD44 with matrix metallopro-
teinases were reported [56–60].
4.5. CD44 and invasive growth
The invasion assays with hippocampal brain slices clearly showed
that overexpression of CD44-mm-GFP is sufﬁcient to promote the
invasion of B35 neuroblastoma cells. This tissue contained ﬁber-like
HA-positive ECM structures (Fig. 8) similar to the ECM organization in
the vicinity of migratory neural precursor cells in mouse cerebellum
[8]. Our ﬁndings extend earlier studies using speciﬁc antibodies
against CD44 or antisense approaches demonstrating that CD44 is
necessary for glioma cell adhesion and invasion in vitro [15] and in
vivo [22]. Upregulation of CD44 was found to be a downstream event
after transformation of ﬁbroblasts necessary for their invasive growth
[36]. Invasive growth, however, involves detachment from neigh-
bouring cells, adhesion to and degradation of the ECM, migration and
survival [1]. It is remarkable that the overexpression of a single protein
that was initially thought to mediate mainly cell adhesion is sufﬁcient
to cause the execution of this complex program of co-ordinated
events. Interestingly, over the years evidence accumulated that CD44rain tissue. Transiently transfected B35 neuroblastoma cells were transplanted in vitro
icroscopy: A, GFP (hatched bars, control); C, EGFR-GFP (black bars), D. CD44-mm-GFP
intensities as described in Material andmethods. Each bar represents the mean of n=5
ed when the signal baseline was reached. Bars, 20 µm. G. Maximal invasion depths: bars
ed bar: GFP (14.06±5.07 µm), black bar, EGFR-GFP (44.09±10.62 µm), open bar, and
rsus GFP control: **, pb0.01).
274 A. Pusch et al. / Biochimica et Biophysica Acta 1803 (2010) 261–274undergoes multiple interactions and fulﬁls diverse tasks which were
summarized as (1) cytokine co-receptor, (2) actin-organizing and (3)
platform functions [10]. This may allow CD44 to regulate simulta-
neously sensing of the environment, cell adhesion, cell motility, and
ECM degradation (and possibly other effects) to promote invasive
growth. Thus, CD44 overexpressionmay be an approach for enhancing
the integration e.g. of ES cell-derived neural precursor cells into the
brain tissue in a therapeutic context. This aspect will be studied in the
future. On the other hand, single molecule microscopy of the
interaction of CD44 with HA as developed in the present study will
allow in the future a more detailed dissection of the function of CD44
in individual membrane bound supramolecular assemblies [37]. This
biophysical view on the cellular and molecular machines in which
CD44 functions will complement the biochemical interaction analyses
of such molecular assemblies to yield a more comprehensive cell
biological understanding of this versatile protein.
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